VINCENT POLIZIO: Open Payments
NPI 1871543611 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,107 in 182 payments from 14 companies in 2025. Trend: 2023 $785 · 2024 $1,292 · 2025 $2,107
Food & beverage: $2,097Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $511 |
| UCB, Inc. | 39 | $397 |
| Novartis Pharmaceuticals Corporation | 24 | $380 |
| Regeneron Healthcare Solutions, Inc. | 18 | $174 |
| PFIZER INC. | 18 | $162 |
| Incyte Corporation | 11 | $142 |
| Amgen Inc. | 9 | $139 |
| Lilly USA, LLC | 3 | $50 |
| Janssen Biotech, Inc. | 3 | $43 |
| Organon LLC | 2 | $30 |
Products named: Bimzelx, SKYRIZI, COSENTYX, DUPIXENT, CIBINQO, OPZELURA, OTEZLA, Rhapsido.
Industry payments across NJ — which companies pay providers there.
